Table 1 Baseline characteristics of hemodialysis patients presenting S. aureus nasal carrier and non-carrier
Characteristic | Carrier (n = 14) n (%)|Mean ± SD | Noncarrier (n = 106) n (%)|Mean ± SD | Total (n = 120) n (%)|Mean ± SD | p-value |
|---|---|---|---|---|
Age | 55.14 ± 17.15 | 54.89 ± 16.10 | 54.9 ± 16.07 | 0.959 |
Female | 11(78.57%) | 50(47.17%) | 61(50.83%) | 0.027 |
BMI | 22.01 ± 6.12 | 23 ± 4.32 | 21.4 ± 4.57 | 0.566 |
Route of hemodialysis | ||||
Double lumen catheter | 1(7.14%) | 5(4.72%) | 6(5%) | 0.696 |
Tunneled hemodialysis catheter | 5(35.71%) | 35(33.02%) | 38(31.67%) | 0.841 |
AVF | 6(42.86%) | 57(53.77%) | 63(52.5%) | 0.442 |
AVG | 2(14.29%) | 9(8.49%) | 11(9.17%) | 0.480 |
Prior antibiotic | 9(32.14%) | 20(21.74%) | 29 (24.17%) | 0.260 |
Immunosuppressive use | 1(7.14%) | 8(7.54%) | 9(7.5%) | 0.957 |
Underlying disease | ||||
Hypertension | 12(85.71%) | 98(92.45%) | 110(91.67%) | 0.391 |
Diabetic | 4(28.57%) | 29(27.36%) | 33(27.5%) | 0.924 |
Dyslipidemia | 11(78.57%) | 47(44.34%) | 58(48.33%) | 0.008 |
SLE | 1(7.14%) | 3(2.83%) | 4(3.33%) | 0.398 |
Skin disease | 1(7.14%) | 5(4.72%) | 6(5%) | 0.696 |
Malignancy | 1(3.57%) | 2(2.17%) | 3(2.5%) | 0.678 |
Renal cell cancer | 1(7.14%) | 0 | 1(0.83%) | 1 |
Prostatic cancer | 0 | 2(1.89%) | 2(1.67%) | 1 |